Tranexamic Acid for the Latarjet Procedure.
Not Applicable
Completed
- Conditions
- Anterior Shoulder Instability
- Interventions
- Drug: Saline
- Registration Number
- NCT03458468
- Lead Sponsor
- Sports Surgery Clinic, Santry, Dublin
- Brief Summary
The investigators propose a double-blinded randomized study evaluating the effectiveness of tranexamic acid in reducing postoperative swelling and haematoma formation after the Latarjet procedure.
The purpose of this study is to assess the efficacy of tranexamic acid (TXA), given via intra-articular injection at the time of surgery in patients undergoing the Latarjet procedure for shoulder instability.
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- COMPLETED
- Sex
- All
- Target Recruitment
- 100
Inclusion Criteria
• Anterior shoulder instability, warranting the Latarjet procedure
Exclusion Criteria
- Patients with known risk factors for hyper-coagulable state
- Patients under 16
- Patients unable to give consent to partake in the trial
Study & Design
- Study Type
- INTERVENTIONAL
- Study Design
- PARALLEL
- Arm && Interventions
Group Intervention Description Group B Saline Saline injection Group A Tranexamic Acid Tranexamic Acid 1g IV
- Primary Outcome Measures
Name Time Method Visual Analogue Scale Postoperative day-1 Opioid consumption Postoperative day-1 Hematoma Formation Postoperative day-1 Patients hematoma formation will be evaluated using the Pauzenberger criteria (Grade 1-4)
Total Drain output Postoperative day-1 The total drain output of blood post-operatively
- Secondary Outcome Measures
Name Time Method Wound complications Postoperative week-2 Total complications Postoperative month-4 Haematoma Formation Postoperative week-2
Trial Locations
- Locations (1)
Sports Surgery Clinic
🇮🇪Santry, Dublin, Ireland